Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of the firm’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $63.28, for a total transaction of $506,240.00. Following the transaction, the president now owns 35,904 shares in the company, valued at approximately $2,272,005.12. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Bruce Caswell also recently made the following trade(s):

  • On Tuesday, September 5th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.23, for a total transaction of $481,840.00.
  • On Wednesday, August 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.50, for a total transaction of $484,000.00.
  • On Thursday, August 10th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $59.83, for a total transaction of $478,640.00.
  • On Thursday, July 27th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.97, for a total transaction of $487,760.00.
  • On Wednesday, July 12th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $62.21, for a total transaction of $497,680.00.

Shares of Maximus, Inc. (MMS) traded down 0.19% during trading on Tuesday, reaching $63.17. 85,727 shares of the company traded hands. Maximus, Inc. has a 12 month low of $43.69 and a 12 month high of $64.97. The company has a 50-day moving average of $60.81 and a 200-day moving average of $61.48. The stock has a market capitalization of $4.10 billion, a PE ratio of 20.25 and a beta of 1.37.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.03. The firm had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.79 earnings per share. Analysts forecast that Maximus, Inc. will post $3.13 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th were issued a $0.045 dividend. The ex-dividend date was Friday, August 11th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. Maximus’s dividend payout ratio (DPR) is currently 5.73%.

COPYRIGHT VIOLATION WARNING: “Insider Selling: Maximus, Inc. (MMS) President Sells 8,000 Shares of Stock” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/19/insider-selling-maximus-inc-mms-president-sells-8000-shares-of-stock.html.

A number of research analysts recently issued reports on MMS shares. BidaskClub lowered shares of Maximus from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 6th. Zacks Investment Research upgraded shares of Maximus from a “hold” rating to a “buy” rating and set a $68.00 price target on the stock in a research report on Saturday, August 5th. Maxim Group set a $66.00 price target on shares of Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Robert W. Baird restated a “hold” rating and issued a $64.00 price target on shares of Maximus in a research report on Friday, September 1st. Finally, Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price target on the stock. in a research report on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. Maximus presently has a consensus rating of “Hold” and a consensus price target of $62.43.

Several hedge funds have recently bought and sold shares of the company. Intl Fcstone Inc. bought a new position in shares of Maximus in the second quarter worth about $201,000. Dynamic Technology Lab Private Ltd bought a new position in shares of Maximus in the second quarter worth about $549,000. Public Employees Retirement System of Ohio lifted its holdings in shares of Maximus by 0.3% in the second quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock worth $4,588,000 after acquiring an additional 207 shares during the last quarter. Koch Industries Inc. bought a new position in shares of Maximus in the second quarter worth about $629,000. Finally, Verition Fund Management LLC bought a new position in shares of Maximus in the second quarter worth about $283,000. 97.23% of the stock is owned by hedge funds and other institutional investors.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.